In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
about
Improving platelet transfusion safety: biomedical and technical considerationsBidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections?Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patients.Efficacy and safety of pathogen-reduced platelet concentrates in children with cancer: a retrospective cohort study.UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function.In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step.Formulation and storage of platelet-rich plasma homemade product.Methods for testing platelet function for transfusion medicine.Update on the use of pathogen-reduced human plasma and platelet concentrates.Peculiarities of studying the effects of pathogen reduction technologies on platelets.Platelet adhesion changes during storage studied with a novel method using flow cytometry and protein-coated beads.Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells.Application of reticulated platelets to transfusion management during autologous stem cell transplantation.Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.Effects of storage duration and volume on the quality of leukoreduced apheresis-derived platelets: implications for pediatric transfusion medicineEvaluation of amotosalem treated platelets over 7 days of storage with an automated cytometry assay panel.Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation.Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets.In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.Amotosalen/UVA pathogen inactivation technology reduces platelet activability, induces apoptosis and accelerates clearance.High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis.Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro.Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro.Evaluation of the tolerability and immunogenicity of ultraviolet C-irradiated autologous platelets in a dog model.Tolerance of platelet concentrates treated with UVC-light only for pathogen reduction--a phase I clinical trial.Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets.
P2860
Q26775408-5DC99CAD-ADD6-4BD6-BA06-56E192F398C3Q33401507-EE71B78D-2D85-498D-B2E1-1E57006A188CQ33416666-CDA196D9-810B-416B-9D6E-5881EEDAAC8DQ33430917-509A52BF-030D-4686-AA34-D8DE70264FF0Q35095651-CBC4C59E-0AE3-4C49-B658-016888E13AEAQ35190154-11985AFD-34E5-417C-A16D-1D7015ACF597Q35265232-143A5E1F-9669-4D01-A9BE-6161D43FBCF0Q36574499-D1083AAD-3FAC-4E0A-B8D1-1CBD20685EB1Q37888815-6B234031-D9F1-411A-89BF-0E980BA46E7DQ38109665-21B2EC87-148F-4242-BB9A-6B625CAD3256Q38812483-BCF01AE5-35D9-4DA4-9E7A-56B8A73AB64FQ39220456-AF68D851-7CFA-47EB-A6A8-A9B36C6F6333Q40099637-67239E4D-3E1D-4A32-B559-05DAC5BE6FCBQ41066613-12591C74-F15E-4D99-BCF3-CAD286AA569EQ41627658-F9135DA6-DE4B-4D4D-A337-19974B600355Q42038158-EDF368E6-05F2-4A8F-B8CC-F6BB4CB95342Q44412209-0F8A3AB6-5AE2-4E97-B05D-540E33D17249Q44827919-32703AAF-708B-49A9-84C3-33252940B901Q46115563-33D00167-785A-475C-9F5F-DCFE807B2F1DQ46743693-CC384757-501C-47A1-A005-DFE7C84F743CQ47134888-23B5915E-FF97-4562-86FA-E8D95D21B5C5Q47901903-5AD4B233-4B9E-4D54-8F4F-0F31D57283D4Q49025509-6D0EC58E-EFDB-4C61-8986-ADA8C74B0D13Q49143801-3C8E3CC8-E84D-4591-8161-EABE0DA369DCQ50515465-B8B9601B-8CA6-406F-9779-AB58B922288CQ53584513-9B4FC8E1-007D-4E40-9269-CEB148397980Q54977038-36E5D265-CE33-4BC7-8A53-2A9FAB51A4E5
P2860
In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
In vitro evaluation of metabol ...... ates during long-term storage.
@en
In vitro evaluation of metabol ...... ates during long-term storage.
@nl
type
label
In vitro evaluation of metabol ...... ates during long-term storage.
@en
In vitro evaluation of metabol ...... ates during long-term storage.
@nl
prefLabel
In vitro evaluation of metabol ...... ates during long-term storage.
@en
In vitro evaluation of metabol ...... ates during long-term storage.
@nl
P2093
P2860
P1433
P1476
In vitro evaluation of metabol ...... ates during long-term storage.
@en
P2093
Anne M Bakken
Solfrid Bjørsvik
Tor Hervig
Torunn Ø Apelseth
Øystein Bruserud
P2860
P304
P356
10.1111/J.1537-2995.2007.01167.X
P577
2007-04-01T00:00:00Z